Key Highlights
- Approximately 2.1 million Americans reported using kratom in 2021
- The global kratom market size was valued at USD 350 million in 2020 and is projected to reach USD 931 million by 2027
- Kratom is derived from the leaves of the Mitragyna speciosa tree native to Southeast Asia
- Approximately 75% of kratom users report primarily using it to manage pain
- The DEA listed kratom as a drug of concern in 2016 but has not classified it as a controlled substance as of 2023
- Kratom contains alkaloids such as mitragynine and 7-hydroxy mitragynine, responsible for its psychoactive effects
- About 60% of kratom users report using it to help with opioid withdrawal symptoms
- The average age of kratom users is estimated to be between 35 and 44 years old
- Kratom is legal in 32 US states as of 2023, with some states banning it
- The FDA has issued multiple consumer advisories warning about the potential risks of kratom
- Kratom's reported benefits include pain relief, mood enhancement, and increased energy, according to user surveys
- The most common side effects reported by kratom users include nausea, constipation, and dry mouth
- There are over 40 different alkaloids identified in kratom leaves, with mitragynine being the most prevalent
Despite its rising popularity and perceived benefits, kratom remains a controversial botanical with a complex legal status and a growing body of research highlighting both its potential as a pain reliever and the risks associated with its use.
Chemical Composition and Pharmacology
- Kratom contains alkaloids such as mitragynine and 7-hydroxy mitragynine, responsible for its psychoactive effects
- There are over 40 different alkaloids identified in kratom leaves, with mitragynine being the most prevalent
- The chemical composition of kratom leaves includes over 40 active compounds, some of which are still under research for their pharmacological effects
- The alkaloid mitragynine can cross the blood-brain barrier, exerting psychoactive effects, according to pharmacological studies
Chemical Composition and Pharmacology Interpretation
Cultural History and Market Trends
- Kratom is derived from the leaves of the Mitragyna speciosa tree native to Southeast Asia
- The first recorded use of kratom as traditional medicine dates back to the 19th century in Southeast Asia, where it was used to increase stamina and manage pain
Cultural History and Market Trends Interpretation
Health Benefits and Risks
- Approximately 75% of kratom users report primarily using it to manage pain
- About 60% of kratom users report using it to help with opioid withdrawal symptoms
- The FDA has issued multiple consumer advisories warning about the potential risks of kratom
- Kratom's reported benefits include pain relief, mood enhancement, and increased energy, according to user surveys
- The most common side effects reported by kratom users include nausea, constipation, and dry mouth
- Kratom withdrawal symptoms can include irritability, hostility, sweating, and muscle aches, similar to opioid withdrawal
- The average user report indicates that kratom dosage varies widely, from 1 to 10 grams per dose, depending on intended effects
- Kratom is sometimes used as a substitute for pharmaceuticals, including opioid painkillers, by individuals seeking an alternative
- Some studies suggest that mitragynine acts as a partial agonist at the mu-opioid receptor, contributing to its analgesic effects
- There is ongoing scientific research into kratom's potential for treatment-resistant depression, though evidence is preliminary
- In 2020, reports of adverse events linked to kratom increased by approximately 40%, according to poison control centers
- Kratom can produce effects ranging from stimulant-like to sedative, depending on dosage, with lower doses acting as stimulants and higher doses as relaxants or opioids
- In some users, kratom can cause allergic reactions, including skin rashes and itching, though these are less common
- The average potency of kratom strain varies, with some strains marketed for their stimulating effects and others for sedative effects, influencing user choice
- Kratom can interfere with prescription medications such as antidepressants and blood thinners, necessitating medical consultation before use
- The majority of kratom-related deaths reported in the US involved polydrug use, often combining kratom with other substances
- Kratom users frequently self-report taking it in doses ranging from 1 gram to 15 grams, with increased doses correlating with stronger sedative effects
- Researchers continue to investigate kratom's potential for reducing opioid dependency without respiratory depression, a prominent concern with traditional opioids
Health Benefits and Risks Interpretation
Legal and Regulatory Status
- The DEA listed kratom as a drug of concern in 2016 but has not classified it as a controlled substance as of 2023
- Kratom is legal in 32 US states as of 2023, with some states banning it
- In 2019, the US FDA issued a ban on kratom imports but it was temporarily lifted, reflecting ongoing regulatory debates
- Kratom's legal status varies worldwide, with some countries banning it entirely such as Australia and Thailand, and others permitting its sale and use
- In 2021, seizures and arrests related to kratom products increased, indicating rising law enforcement attention
- Despite its traditional use in Southeast Asia for centuries, kratom's rise as a supplement in Western countries has increased regulatory scrutiny
- Kratom is scheduled as a controlled substance in countries like Singapore, Malaysia, and Thailand, where its use is strictly prohibited
- Kratom's legal landscape is evolving, with several states and localities proposing bans or restrictions as research into its safety continues
Legal and Regulatory Status Interpretation
Market Size and Usage Demographics
- Approximately 2.1 million Americans reported using kratom in 2021
- The global kratom market size was valued at USD 350 million in 2020 and is projected to reach USD 931 million by 2027
- The average age of kratom users is estimated to be between 35 and 44 years old
- It is estimated that less than 1% of US adults have tried kratom, indicating it remains a niche but growing substance of interest
- Kratom is often sold in head shops, online, and in some local markets, with online sales accounting for over 70% of transactions in the US
- A survey found that approximately 80% of kratom users are male, with females comprising about 20%, indicating a gender disparity in usage
- Kratom's popularity has grown significantly in the US over the past decade, with a 5-fold increase reported from 2011 to 2021
- The majority of kratom users report taking it orally in powder, capsule, or tea form, with less common routes including inhalation of vaporized leaves
- The percentage of high school students reporting recent kratom use remains below 1%, indicating relatively low adolescent experimentation
Market Size and Usage Demographics Interpretation
Sources & References
- Reference 1CDCResearch Publication(2024)Visit source
- Reference 2GLOBENEWSWIREResearch Publication(2024)Visit source
- Reference 3NCBIResearch Publication(2024)Visit source
- Reference 4ADVISORYResearch Publication(2024)Visit source
- Reference 5DEAResearch Publication(2024)Visit source
- Reference 6PUBMEDResearch Publication(2024)Visit source
- Reference 7STATISTAResearch Publication(2024)Visit source
- Reference 8KINETIXWEIGHSResearch Publication(2024)Visit source
- Reference 9FDAResearch Publication(2024)Visit source
- Reference 10WEBMDResearch Publication(2024)Visit source
- Reference 11DRUGABUSEResearch Publication(2024)Visit source
- Reference 12WORLDATLASResearch Publication(2024)Visit source
- Reference 13JUSTICEResearch Publication(2024)Visit source
- Reference 14WHOResearch Publication(2024)Visit source
- Reference 15ECANCERResearch Publication(2024)Visit source
- Reference 16LEGALMATCHResearch Publication(2024)Visit source
- Reference 17JURNALTHROMBOSISResearch Publication(2024)Visit source